<p>DBV Technologies S.A. (NASDAQ:DBVT - 获取免费报告) 在周一交易中跌破了其五十日移动平均线。该股票的五十日移动平均线为 0.89 美元，最低交易价为 0.85 美元。DBV Technologies 股票最新交易价为 0.90 美元，成交量为 2,500 股。</p>
<p>获取 <strong>DBV Technologies</strong> 警报：</p>
<h2>分析师评级变动</h2>
<p>多家股票研究分析机构对 DBVT 股票发表了意见。StockNews.com 在周二的一份报告中对 DBV Technologies 股票进行了覆盖。他们给予该股票 “持有” 评级。JMP Securities 将 DBV Technologies 股票的目标价格从 4.00 美元提高到 5.00 美元，并在 7 月 31 日星期三的研究报告中给予该股票 “市场表现优异” 评级。最后，HC Wainwright 重申了对 DBV Technologies 股票的 “买入” 评级，并设定了 5.00 美元的目标价，报告发布于 8 月 1 日星期四。</p>
<p>获取我们对 DBV Technologies 的最新股票分析</p>
<h2>DBV Technologies 股票表现</h2>
<p>该公司的五十日简单移动平均线为 0.89 美元，两百日简单移动平均线为 1.19 美元。该股票的市值为 8685 万美元，市盈率为-1.07，贝塔系数为 0.68。</p>
<p>DBV Technologies (NASDAQ:DBVT - 获取免费报告) 上次公布季度财报是在 7 月 30 日星期二。公司报告该季度每股亏损为（0.34）美元，低于市场预期的（0.26）美元。DBV Technologies 的净资产收益率为-74.41%，净利润率为-638.21%。该季度营收为 116 万美元，低于市场预期的 142 万美元。去年同期，该公司每股亏损为（0.26）美元。分析师预计，DBV Technologies S.A.本财年将实现-1.43 美元的每股盈利。</p>
<h2>DBV Technologies 的机构交易</h2>
<p>一家机构投资者最近在 DBV Technologies 股票中建立了新头寸。根据最新提交给证券交易委员会（SEC）的 13F 文件，Cowen AND Company LLC 在第四季度购入了 DBV Technologies S.A.（NASDAQ:DBVT - 免费报告）的新头寸。该公司购入了 50986 股该公司的股票，价值约为 49,000 美元。对冲基金和其他机构投资者拥有该公司股票的 71.74%。</p>
<h2>关于 DBV Technologies（获取免费报告）</h2>
<p>DBV Technologies SA 是一家临床阶段的生物制药公司，致力于研发经皮免疫疗法产品。其产品管线包括 Viaskin Peanut，一种已完成第 3 期临床试验的免疫疗法产品，用于治疗花生过敏；以及 Viaskin Milk，目前处于第 1/2 期临床试验阶段，用于治疗免疫球蛋白 E（IgE）介导的牛奶蛋白过敏和嗜酸性食道炎。</p>
<h2>精选文章</h2>
<ul>
<li>我们喜欢的五支股票胜过 DBV Technologies</li>
<li>什么是股息争夺者？投资于股息争夺者</li>
<li>Autodesk 股票：分析师的首选人工智能股票，不容忽视</li>
<li>波动时期的 3 支必买沃伦·巴菲特股票</li>
<li>理想汽车在艰难季度中的隐藏机会，不容错过</li>
<li>投资中的不同股票类型</li>
<li>不要忽视康宝食品：这是可能推动其股价的因素</li>
</ul>
<p><em>此即时新闻警报由叙事科技生成，使用了 MarketBeat 的财务数据，以向读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 我免费提供这项投资的名称（来自 Porter &amp; Company）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjQ1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjQ1"/></p>
<h2>您现在是否应该投资 1,000 美元购买 DBV Technologies？</h2>
<p>在考虑 DBV Technologies 之前，您应该听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高且表现最佳的研究分析师以及他们推荐给客户的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票...而 DBV Technologies 不在名单上。</p>
<p>尽管 DBV Technologies 目前在分析师中有 “持有” 评级，但顶级分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

DBV 科技

<p>DBV Technologies（纳斯达克：DBVT）股票已跌破其 50 日移动平均线，最低交易至{{.Question}}.85 美元。分析师们给予 “持有” 评级，并设定了各种价格目标，其中 JMP 证券提高了他们的目标。第二季度，DBV 报告了每股（{{.Question}}.34）的亏损，未达到预期，营收为 1600 万美元。机构持股比例为 71.74%。DBV 是一家专注于免疫治疗产品的临床阶段生物制药公司，包括用于花生过敏的 Viaskin。分析师预测，DBV 将在本财年报告-1.43 美元的每股收益</p>

<p>DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.89 and traded as low as $0.85. DBV Technologies shares last traded at $0.90, with a volume of 2,500 shares changing hands.</p>
<div class="lb-trans"><p>DBV Technologies S.A. (NASDAQ:DBVT - 获取免费报告) 在周一交易中跌破了其五十日移动平均线。该股票的五十日移动平均线为 0.89 美元，最低交易价为 0.85 美元。DBV Technologies 股票最新交易价为 0.90 美元，成交量为 2,500 股。</p>
</div><p>Get <strong>DBV Technologies</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>DBV Technologies</strong> 警报：</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of equities research analysts have weighed in on DBVT shares. StockNews.com assumed coverage on shares of DBV Technologies in a report on Tuesday. They set a &#34;hold&#34; rating on the stock. JMP Securities boosted their price objective on shares of DBV Technologies from $4.00 to $5.00 and gave the stock a &#34;market outperform&#34; rating in a research note on Wednesday, July 31st. Finally, HC Wainwright reaffirmed a &#34;buy&#34; rating and set a $5.00 target price on shares of DBV Technologies in a report on Thursday, August 1st.</p>
<div class="lb-trans"><p>多家股票研究分析机构对 DBVT 股票发表了意见。StockNews.com 在周二的一份报告中对 DBV Technologies 股票进行了覆盖。他们给予该股票 “持有” 评级。JMP Securities 将 DBV Technologies 股票的目标价格从 4.00 美元提高到 5.00 美元，并在 7 月 31 日星期三的研究报告中给予该股票 “市场表现优异” 评级。最后，HC Wainwright 重申了对 DBV Technologies 股票的 “买入” 评级，并设定了 5.00 美元的目标价，报告发布于 8 月 1 日星期四。</p>
</div><p><strong>Get Our Latest Stock Analysis on DBV Technologies</strong></p>
<div class="lb-trans"><p>获取我们对 DBV Technologies 的最新股票分析</p>
</div><h2>DBV Technologies Stock Performance</h2>
<div class="lb-trans"><h2>DBV Technologies 股票表现</h2>
</div><p>The firm's fifty day simple moving average is $0.89 and its 200-day simple moving average is $1.19. The stock has a market cap of $86.85 million, a P/E ratio of -1.07 and a beta of 0.68.</p>
<div class="lb-trans"><p>该公司的五十日简单移动平均线为 0.89 美元，两百日简单移动平均线为 1.19 美元。该股票的市值为 8685 万美元，市盈率为-1.07，贝塔系数为 0.68。</p>
</div><p>DBV Technologies (NASDAQ:DBVT - Get Free Report) last posted its quarterly earnings data on Tuesday, July 30th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.08). DBV Technologies had a negative return on equity of 74.41% and a negative net margin of 638.21%. The business had revenue of $1.16 million during the quarter, compared to the consensus estimate of $1.42 million. During the same period last year, the business posted ($0.26) earnings per share. Analysts predict that DBV Technologies S.A. will post -1.43 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>DBV Technologies (NASDAQ:DBVT - 获取免费报告) 上次公布季度财报是在 7 月 30 日星期二。公司报告该季度每股亏损为（0.34）美元，低于市场预期的（0.26）美元。DBV Technologies 的净资产收益率为-74.41%，净利润率为-638.21%。该季度营收为 116 万美元，低于市场预期的 142 万美元。去年同期，该公司每股亏损为（0.26）美元。分析师预计，DBV Technologies S.A.本财年将实现-1.43 美元的每股盈利。</p>
</div><h2>Institutional Trading of DBV Technologies</h2>
<div class="lb-trans"><h2>DBV Technologies 的机构交易</h2>
</div><p>An institutional investor recently bought a new position in DBV Technologies stock. Cowen AND Company LLC purchased a new position in DBV Technologies S.A. (NASDAQ:DBVT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 50,986 shares of the company's stock, valued at approximately $49,000. Hedge funds and other institutional investors own 71.74% of the company's stock.</p>
<div class="lb-trans"><p>一家机构投资者最近在 DBV Technologies 股票中建立了新头寸。根据最新提交给证券交易委员会（SEC）的 13F 文件，Cowen AND Company LLC 在第四季度购入了 DBV Technologies S.A.（NASDAQ:DBVT - 免费报告）的新头寸。该公司购入了 50986 股该公司的股票，价值约为 49,000 美元。对冲基金和其他机构投资者拥有该公司股票的 71.74%。</p>
</div><h2>About DBV Technologies (Get Free Report)</h2>
<div class="lb-trans"><h2>关于 DBV Technologies（获取免费报告）</h2>
</div><p>DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis.</p>
<div class="lb-trans"><p>DBV Technologies SA 是一家临床阶段的生物制药公司，致力于研发经皮免疫疗法产品。其产品管线包括 Viaskin Peanut，一种已完成第 3 期临床试验的免疫疗法产品，用于治疗花生过敏；以及 Viaskin Milk，目前处于第 1/2 期临床试验阶段，用于治疗免疫球蛋白 E（IgE）介导的牛奶蛋白过敏和嗜酸性食道炎。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than DBV Technologies</li>
<li>What Are Dividend Contenders? Investing in Dividend Contenders</li>
<li>Autodesk Stock: Analysts' Top AI Pick You Shouldn’t Overlook</li>
<li>3 Must-Buy Warren Buffett Stocks for Volatile Times</li>
<li>Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss</li>
<li>There Are Different Types of Stock To Invest In</li>
<li>Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock</li>
</ul>
<div class="lb-trans"><h2>精选文章</h2>
<ul>
<li>我们喜欢的五支股票胜过 DBV Technologies</li>
<li>什么是股息争夺者？投资于股息争夺者</li>
<li>Autodesk 股票：分析师的首选人工智能股票，不容忽视</li>
<li>波动时期的 3 支必买沃伦·巴菲特股票</li>
<li>理想汽车在艰难季度中的隐藏机会，不容错过</li>
<li>投资中的不同股票类型</li>
<li>不要忽视康宝食品：这是可能推动其股价的因素</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科技生成，使用了 MarketBeat 的财务数据，以向读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ I’m giving you the name of this investment for free (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 我免费提供这项投资的名称（来自 Porter &amp; Company）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjQ1" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9245&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in DBV Technologies right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1,000 美元购买 DBV Technologies？</h2>
</div><p>Before you consider DBV Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 DBV Technologies 之前，您应该听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DBV Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高且表现最佳的研究分析师以及他们推荐给客户的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票...而 DBV Technologies 不在名单上。</p>
</div><p>While DBV Technologies currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 DBV Technologies 目前在分析师中有 “持有” 评级，但顶级分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

DBV Technologies（纳斯达克代码：DBVT）股价跌破 50 日移动平均线 0.89 美元